HD-Ad vectors for airway expression, using control elements from the human cytokeratin 18 (K18) gene to drive expression of the CFTR transgene were developed for CF gene therapy and showed promise in preclinical studies. This evidence concerns the gene KRT18 and cystic fibrosis.